Clinical Trials Browser

Phase 1/2 × Withdrawn × OTHER_GOV × Clear all

NCT02115672 2016-08-15

Imatinib and BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous Leukemia

Phase 1/2 Withdrawn

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01880996 2015-06-11

Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies

Phase 1/2 Withdrawn

Fatigue, Ovarian Neoplasms, Parasomnias